Effects of Expression of Transcriptional Factor AP-1 FOSL1 Gene on Psoriatic Process

被引:17
作者
Sobolev, V. V. [2 ]
Zolotorenko, A. D. [2 ]
Soboleva, A. G. [2 ]
Elkin, A. M. [1 ]
Il'ina, S. A. [1 ]
Serov, D. N. [3 ]
Potekaev, N. N. [3 ]
Tkachenko, S. B. [3 ]
Minnibaev, M. T. [3 ]
Piruzyan, A. L. [1 ]
机构
[1] Russian Acad Sci, Ctr Theoret Problems Phys & Chem Pharmacol, Moscow, Russia
[2] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia
[3] IM Sechenov Moscow Med Acad, Moscow, Russia
关键词
psoriasis; gene expression; real time polymerase chain reaction; FOSL1; SQUAMOUS-CELL CARCINOMA; BINDING-ACTIVITY; FRA-1; OVEREXPRESSION; REQUIRES; SKIN;
D O I
10.1007/s10517-011-1208-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We performed quantitative analysis of FOSL1 gene expression in lesional psoriatic skin. The expression of this gene in lesional psoriatic skin was significantly increased compared to that in unaffected areas. Enhanced FOSL1 expression significantly correlated with high psoriasis area and severity index (PASI). High level of FOSL1 gene expression was proposed to be a marker of pathological process activity in psoriasis.
引用
收藏
页码:632 / 634
页数:3
相关论文
共 15 条
  • [1] Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements
    Adiseshaiah, P
    Peddakama, S
    Zhang, Q
    Kalvakolanu, DV
    Reddy, SP
    [J]. ONCOGENE, 2005, 24 (26) : 4193 - 4205
  • [2] Hu YC, 2001, CLIN CANCER RES, V7, P2213
  • [3] Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin
    Johansen, C
    Kragballe, K
    Rasmussen, M
    Dam, TN
    Iversen, L
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (03) : 600 - 607
  • [4] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
    Livak, KJ
    Schmittgen, TD
    [J]. METHODS, 2001, 25 (04) : 402 - 408
  • [5] Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma
    Mangone, FRR
    Brentani, MM
    Nonogaki, S
    Begnami, MDFS
    Campos, AHJFM
    Walder, F
    Carvalho, MB
    Soares, FA
    Torloni, H
    Kowalski, LP
    Federico, MHH
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (04) : 205 - 212
  • [6] Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
    Nickoloff, BJ
    Nestle, FO
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (12) : 1664 - 1675
  • [7] Transcription factor AP-1 components as psoriasis candidate genes
    Piruzian, E. S.
    Nikolskaya, T. A.
    Abdeev, R. M.
    Brouskin, S. A.
    [J]. MOLECULAR BIOLOGY, 2007, 41 (06) : 974 - 985
  • [8] A comparative analysis of the molecular genetic processes in the pathogenesis of psoriasis and Crohn's disease
    Piruzian, E. S.
    Ishkin, A. A.
    Nikol'skaya, T. A.
    Abdeev, R. M.
    Bruskin, S. A.
    [J]. MOLECULAR BIOLOGY, 2009, 43 (01) : 159 - 165
  • [9] Ramos-Nino ME, 2003, CANCER RES, V63, P3539
  • [10] Ramos-Nino ME, 2002, CANCER RES, V62, P6065